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Abstract 
 The purpose of this review is to highlight the advances in technology and 
understanding in the field of breath analysis for medical diagnosis. A critical review of the 
methods of breath collection, treatment, and analysis is given, highlighting the problems 
facing the field and areas where promising advancement has been made. One particular area 
of interest is centered around electronic noses, ideally, portable devices which aim to mimic 
biological olifactory systems in analysing gases to produce odor fingerprints. Furthermore, 
recent work has shown it is possible to modify the basic sensor materials to both improve 
their performance, increase their tolerance to factors such as water vapour interferance which 
often leave the sensor system de-sensitized to the gaseous biomarkers, and enhance their 
selectivity. It will be shown how it is possible to accurately quantify concentrations of VOC’s 
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and make disease diagnosis from analysis of the collected data which compare favorably with 
traditional medical diagnostic techniques.  
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Introduction 
 
 Since the time of the ancient Greeks, physicians have acknowledged the potential of 
exhaled breath (EB) as a diagnostic tool for disease and underlying health conditions. It is 
possible, through breath odour to identify the telltale sweet, fruit like scent of acetone, and 
hence the underlying diabetes of a patient, the stench attributable to a lung absyss, and the 
fumes of urine, an indication of kidney disease (1).  
 
 Contemporary research dawned with the identification of ≈250 common volatile 
organic compounds, (VOC’s) in exhaled breath (2). Whilst the practicality of the study was 
of low value, (the study group having to follow a severely restricted diet of simple molecules 
for several days) it was a first step in identifying potential bio-markers of disease. Initial 
studies relied on simple gas chromatography (GC) sampling methods, with no sample 
fractionalisation of preconcentration. Computational advancement through the 80’s and 90’s 
made it possible for breath tests to be used routinely in clinical analysis for example to 
identify blood ethanol levels and the diagnosis of a Helicobacter pylori bacterial infection 
using 
13/14
C-urea as a biomarker (3). 
 
 Due to its non-invasivity breath analysis is an attractive procedure for disease 
diagnosis however challenges remain. One of the biggest obstacles faced is linking the 
suspected biomarkers back to the metabolic pathways that occur as a result of the underlying 
health condition as many of these pathways are, as of yet, unkown. Likewise technological 
and procedural difficulties remain. Standardization of sample collection, preconcentration 
and vapour-desorption is key to making breath analysis both economical and practical in its 
use.  
 
The Collection, Preconcentration & Desorption of Exhaled Breath: 
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 Over 1000 VOC’s have been identified to date with most being in the ppmv down to 
pptv concentrations as such it is essential that the sample collection and pre-concentration are 
required to make detection possible. 
 
 Sample collection requires the distinction between ‘dead air’ space, representing the 
first ≈150ml of air collected, (originating from the mouth an upper airway where no exchange 
is possible between the blood and breath) and ‘alveolar breath’ represented by the next 
≈350ml of exhaled breath (1). Studies have shown that whilst concentrations of some 
chemical species, and the pH are not vastly different between these two collections of 
exhaled air (cited adenosine, hydrogen peroxide and 8-isoprostane) other potential biomarker 
concentrations vary according to the breath origin. In one study it was found that the 
concentration of ammonia was substantially lower in exhaled breath samples obtained 
through tracheostomies than those collected via the mouth, suggesting the origin of this 
compound is in the upper airways (4). Hence, depending on the biomarker being observed, 
inclusion of dead space air can be a contaminant or a necessity as is the case with nitrogen 
oxide, proposed as  a biomarker of respiratory inflammation (5). 
 
 The interaction of VOC’s with water vapour, comprising 99% by volume of liquid 
exhalants is another important consideration when prescribing a standardized collection 
method. Studies have shown a reduced concentration of key VOC’s due to their absorption 
into water condensate in the collection apparatus (6). Further study found no significant loss 
of VOC’s in tedlar collection bags under typical conditions. Loss of acetone, and 2-butanone 
were seen, but only in conditions in which at least three times the normal volume of exhaled 
water vapour was present (7). The study did find that water vapour impedes the functioning 
and sensitivity of GC apparatus, as a consequence, water vapour collection was strongly 
recommended before analyte concentration. Further to this, the effect of water vapour on 
metal oxide sensor arrays has been documented. Generally, an increase in humidity has an 
associated increase in conductivity / decrease in resistivity. This is believed to be due to 
displacement of chemisorbed oxygen species by water molecules and hydroxyl species which 
form at the sensor surface. These lie higher in energy that the predecessor oxygen species 
displaced. (8) 
 
 Preconcentration requires that the EB be passed through a chemical trap which 
selectively absorbs analytes of interest. Methods include: chemical interaction, resin 
adsorption, and cryogenic distillation (“cold trapping”). Ideal traps would completely adsorb 
the volatile organic from the passing breath, and then release completely upon desorption, 
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usually via thermal decomposition, with no loss or contamination. Current devices fail to 
meet these criteria. Chemical trapping, the process of passing the EB through a solution that 
actively captures compounds, is usually ultra specific. This is advantageous when only one 
analyte is being measured, one case in point being acetone.   
 
 Large concentrations of acetone have been identified in patients with acute diabetes. 
Techniques to quantify this presence involve bubbling the EB through an alkaline iodine 
solution (9) and reacting the EB with 2,4-dinitrophenylhydrazine (fig.1): 
 
 
 
Fig 1. Reaction of a ketone with 2,4-dinitrophenylhydrazine to give the corresponding hydrazone which can be 
quantitatively measured to determine the original concentration of ketone. Comparable to the measurement of 
acetone in exhaled breath in diabetic patients (10). 
 
 The above method has one critical limitation in that it requires breath sampling for 
upwards of an hour. Most recently research has involved (basic) salicylaldehyde (SA) 
chemistry which has a measurement cycle of a more practical ten minutes with a detection 
limit of just 14 ppbv for acetone. The SA reaction requires initial basic conditions, as treated 
with NaOH (≈0.8M), to prevent the water insoluble SA from forming a separated bilayer on 
top of the water. The reaction proceeds as an aldol condensation producing a blue product 
which was measured using colorimetric diagnostic techniques (11). 
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 In contrast cold traps generally capture unwanted chemical compounds and as such 
are generally too unspecific. As a result, adsorbent trapping is the most convenient and 
widely used trapping technique. It captures volatiles on an extracting phase, polymer if liquid, 
sorbent is solid, and then releases these, as and when required into the separating apparatus. 
Solid Phase Microextraction (SPME) is such a technique developed by Dr. Pawliszyne, of the 
University of Waterloo, comparatively advantageous in that it requires no solvent and 
importantly for practicality reasons, can be done in-field by non scientific staff. Several days 
can pass before the analysing process without significant loss of volatiles. Concentrations as 
low as pptv have been successfully adsorbed, enhanced by the use of low-temperature glassy 
carbon (LTGC) microfibers.   
 
 The selectivity and efficiency of commercially available poly(dimethylsiloxane) / 
divinylbenzene (PDMS/DVB) fibers compared with LTGC fibers has been examined and the 
following graph illustrates the enhancement gained when using the latter (fig.2): 
 
 
 
Fig 2. Extraction recovery efficiencies of commercially available PDMS/DVB with LTGC fibers in relation to 
certain VOC’s. 
 
 As can be seen in all cases there was a dramatic increase in the extraction of VOC’s 
when the low-temperature glassy carbon tubes were used, an improvement by a factor of 
approximately ≈5. Conclusions of the study reported that VOC’s could be successfully 
adsorbed in the subpicomolar concentrations, more than adequate for the majority of VOC’s 
found in EB (12). 
 
Techniques for Breath Testing: 
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  Currently, instrumental detection of breath biomarkers can be split into two subgroups. 
Conventional methods that utilise GC, usually coupled with a form of mass spectroscopy 
(MS), and electronic analysis via the use of sensors, commonly found in the form of 
electronic noses, or e-noses. Electronic noses consist of sensor arrays that are usually specific 
in response to certain gases, and aim to mimic biological olfactory systems, through 
determination of concentration of gases. Generally, e-noses are cheaper, portable and faster, 
commonly requiring less than 30 minutes to analyse a sample. Whilst e-noses are already 
deployed in industry, from fields as diverse as food, fragrances, chemistry and the 
environment. (13) The use of e-noses in medical diagnosis has shown promising results in the 
fields of renal disease, lung cancer and diabetes, however the devices tend to be too specific 
and lack cross compatibility, suitable for one particular disease only.  
 
 The former technique involves injecting the analyte onto the head of the 
chromatographic column and then passed through the column under the continuous pressure 
from an inert gaseous phase. As the analyte travels through the column, the different 
constituents separate out, in an order largely dependant upon the material used to pack the 
column. Silicones tend to separate analytes according to boiling point whereas polar packing 
materials instead separate according to the relative polarities of the species (14).  
 
 Further analysis most commonly employs mass spectroscopy (MS) to identify the 
separated species, using the difference in mass-to-charge ratio (m/e) to define ions or charged 
molecular fragments. Currently this method of determination is the primary procedure 
utilised to identify VOC’s in human breath. Comparative studies have shown however that 
there is little difference in accuracy of determination even with low concentration (ppbv) 
organics compared with other detection techniques (15). The study involved the detection of 
108 organics in human breath, using both real time and canister analysis. It was found that 
many of the analytes where present in too low concentrations to be detected by either method 
of detection, MS and Flame Ionized Detection (FID), (noting that preconcentration of the 
sample is therefore a stringent requirement). Hence the sample study was reduced to just a 
few organics, including isoprene and α-prinene (biological hydrocarbons), benzene and 
toluene (anthropogenic hydrocarbons) within that subset. The study found that there was no 
significant difference in the accuracy’s of either method, the extent of agreement described as 
‘excellent’ an observation even more prominent when both MS and FID were independently 
calibrated  
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  FID exploits the phenomenon whereby charged ions and electrons are released upon 
igniting organic compounds that have been mixed with hydrogen and air. These charged 
species are able to carry charge, which is measured and calibrated to detect the species 
present (16). One severe limitation over MS that cannot be overcome is that during the 
detection process FID destroys the sample, making subsequent or indeed more in depth 
analysis impossible. 
 
 Another analysis method is Ion Mobility Spectrometry (IMS). This method calibrates 
the relative delay in reaching a detector of charged ions and molecules. Such species travel at 
velocities proportional to their size, shape, mass and charge, hence individual identification is 
possible. The ion mobility, K, is defined as the proportionality factor of an ion's drift velocity 
vd in a gas and an electric field of strength E (eq.1): 
 
vd = KE      (eq.1) 
 
The ion mobility K can be experimentally determined by measuring the drift time tD of an ion 
travelling within a homogeneous electric field with potential difference U in the drift length L 
(eq.2): 
 
                    (eq.2) 
 
The ion mobility K can also be calculated by the Mason equation (eq.3): 
 
                          (eq.3) 
  
where Q is the ion charge, n is the drift gas number density, μ is the reduced mass of the ion 
and the drift gas molecules, k is Boltzmann constant, T is the drift gas temperature, and σ is 
the ion’s collision cross section with the drift gas. This relation holds approximately at a low 
electric field limit, where the ratio of E/n is small, at ≤ 2 x 10-17 C•cm2 (17).  
 
 IMS can be integrated with MS (IMMS) with each complementing and enhancing the 
others accuracy and efficiency. Together it becomes a power analytical tool for identifying 
molecular structure and separating complex samples which MS alone might not be able to 
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distinguish. Studies have found the resolving power of IMMS to be in the region of 50-120 
which is similar to capillary gas chromatography (18). 
 
 Proton Transfer Mass Spectrometry, (PMT-MS) is another promising field able to 
analyze analyte concentrations as low as a few pptv. This relies on protonation of the 
chemical species, coming from a transfer from protonated water. Almost all VOC’s have 
proton affinities greater than water, hence there is complete transfer (19). The technique is 
particularly advantageous for breath analysis as large volumetric contributions from N2, O2, 
CO2 and water do not interfere with measurement. Like MS, species identification is done 
purely on an m/e ratio, meaning that mass overlapping is possible when fragmentation occurs. 
For increased accuracy, PMT-MS is usually coupled with GC to provide additional 
separation (20). 
 
Importance of Background Correction: 
 
 Not only can contamination arise due to the inclusion of dead air space, but also from 
exogenous contaminants. It is not to be overlooked that exhaled breath is by more than any 
other variable, affected by what the patient is exposed to in terms of inhaled air. To 
standardize a sampling procedure this therefore mulct be addressed.  
 
 A simple solution would be to have the patient breath pure, supplied air for a 
designated period of term pre-measurement. However this has its practical limitations, 
especially in a non-controlled environment. A more advantageous approach would be to 
subtract exogenous concentrations from the EB. Thereafter, the difference in concentration 
between environmental and EB would correspond to the alveolar gradient. A measurement 
that can be used to determine a VOC’s origination, either external or metabolic (21). 
 
 Once these standards for background correction have been adopted it should be 
possible to create normal concentration ranges of VOC’s for humans, respective of different 
physiological and sociological variables (ethnicity, age, smoking status etc.). Once these 
accepted ranges are in place it should be possible to detect cases if abnormal physiology and 
disease (22) 
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The Application of Sensors and Portable Devices to Medical Breath Analysis 
 
 The past forty years have yielded a vast array of information on the identity of volatile 
organic compounds that are present in exhaled breath using,  what is considered, bench top 
analytical chemistry. The drive of recent research efforts has focussed on the development of 
portable, compact analytical devices tailored to the needs of the patient. One of the major 
obstacles facing sensor development is the requirement to measure multiple analytes with 
sensitivity down to trace concentrations (ppbm) in non-standard changing environments (23) 
 
 One branch of the sensor field revolves around chemo-resistive detectors based upon 
semiconductor metal oxide films. Popular sensing materials include SnO2, TiO2, ZnO, In2O3, 
and WO3 of which the latter in crystalline form has been intensively studied as a detector for 
acetone, a known biomarker of diabetes (24). Current sensors adapt the γ-phase due to it s 
stability at room temperature and has been used to detect NOx, NH3, H2S and O3 (25).  
 
 The ε-phase (being monoclinic and having the lowest symmetry number of all 
observed phases) in contrast is stable at temperatures below ≈230 K and is the only phase to 
be acentric, arising from the shift in the central tungsten atom at the centre of the octahedral 
unit cell that comes with a phase change from δ-to-ε WO3 (26). This has a significant impact 
upon the physical properties of the solid; most notably that it displays ferroelectric attributes 
(it has a spontaneous polarizability when introduced to an external electrical field). Hence the 
utility of ε-WO3 in chemical sensors is only valid once a method of stabilizing the phase 
above 230K and above, ideally to the normal room temperature ranges.  
 
 Such work has been carried out by L. Wang et al. synthesizing tungsten trioxide 
nanoparticles by means of flame spray pyrolysis (FSP) using Chromium dopants to stabilise 
the ε-phase. Due to the rapid succession of formation and deposition it is believed that there 
is simply not enough time for the thermodynamically favoured positions of the W and O 
atoms to settle, hence the lowest symmetry polymorph is favoured. The effect of doping is to 
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distort the matrix, with the chromium atoms repelling the Tungsten atoms from their central 
positions, hence promoting the acentric ε-phase. 
 
  The potential advances in chemical sensor manufacture via FSP are many fold. The 
method allows for direct deposition of sensing films directly from the flame onto the sensor 
electrodes. This is in marked contrast to traditional wet chemistry placement which is tedious 
and contamination prone. This contrast can be seen in the methodology diagram below (fig.3), 
depicting the preparation of an Pt-doped SnO2 chemical sensor (27). 
 
 
Fig.3 Schematic diagram showing the contrasting methods of FSP and traditional wet chemistry methods in the 
preparation of a SnO2 coated sensor. 
 
 Further studies using FSP made sensing films found that these films exhibited high 
homogeneity (crack free surfaces) and a greater level of sensitivity. High porous Pt-doped 
SnO2 films were shown to have sensitive down to 1ppm for CO in dry air at 350  C (28). 
 
 In Wang’s investigation, 10% Cr-doped ε-WO3 nanoparticles were measured for their 
sensitivity in investigating acetone, at concentrations of 0.2, 0.5 and 1 ppm, well within the 
reported 1-diabetes attributed concentrations of >1.8ppm and <0.8ppm in healthy patients 
(29). The following graph (fig.5) shows the electronic resistivity of the sensor to acetone in 
human breath: 
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Fig.5 Resistance change of 10 atom % Cr-doped WO3 with exposure 
to acetone at 400˚C. 
 
 ˚As can be seen, the WO3 shows high sensitivity to acetone down to concentrations of 
1ppm. Moreover, it was found that consecutive cycles of acetone gas were introduced the 
sensor remained stable. With a response time of less than 10 seconds, the production of a real 
time, highly selective, highly sensitive portable sensor is promising. The authors found that 
the high sensitivity of the device did not transcend to other gases. It is believed that the highly 
polar acetone is unique in its interaction with the ferroelectric ε-WO3, a relationship which 
would not be replicated if the Tungsten oxide where in a non-acentric, hence non-
ferroelectric phase.  
 
 An alternative to doping with the potentially toxic chromium with silicon is presented 
by Marco Righettoni et al. Si is used in the same capacity as Cr, that is to thermally stabilise 
the ε-WO3 to the operating temperatures of metal oxide chemical sensors (300-500 C). 
Moreover, the sensor is tested against non-ideal conditions involving water vapour and the 
common VOC ethanol found in EB (30). The setup consisted of a Tungsten trioxide film 
deposited onto a sensor substrate consisting of an Al2O3 support with Gold electrodes (fig.6).  
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Fig. 6 Setup of the Si doped WO3 sensor for the detection of acetone. 
 
The operation of the sensor is measured with respect to the sensor response, S, (eq.4) and the 
cross-sensitivity to humidity, CS (eq.5) 
 
1/RRS analyteair                                                     (eq.4) 
100])/SSabs[(SCS dryRHdry                                         (eq.5) 
 
Where R is the film resistance, at a given concentration, and SRH is the sensor response at a 
known relative humidity. The study found that S was reproducible between 100 and 600 ppb 
acetone with a maximum variation of ±9%. The effect of Si doping was that with increased 
concentration, the WO3 particle size decreased [average grain size of non-doped WO3 – 13nm, 
10% Si doped – 12nm ad 20% Si-doped – 10nm].  
 
 Previous work had shown that Si doping decreased the sintering rate of metal oxide 
films (31) and significantly increased the thermal stability range of WO3, hence increasing 
the sensitivity to acetone (32). The increased sensitivity has been attributed to the smaller 
‘neck size’ that is the heterojunction formed between, in the study referenced, SnO2-SiO2 
particles (whereby SnO2 is analogous to WO3) and not the decrease in particle grain size. In 
fact, sensor gas sensitivity to ethanol was found to only increase with Si doping that resulted 
in interstitial Si atoms within the metal oxide lattice which inhibit particle grain growth. 
Excess doping leading to SiO2 deposits on the surface of the film led to isolation of the metal 
oxide particles and a resulting decrease in measured sensitivity.  
 
 Furthermore, Si doping was found to significantly increase the relative composition of 
ε-WO3 compared to previous studies on sol-gel made SiO2-WO3 nanoparticles. A 20% 
doping composition lead to 100% (by weight) ε-WO3 whereas sol-gel based systems to 
measure NO2 concentrations led to pure γ-WO3 (33).  
 
 The real measure of the sensor is in its ability to accurately determine concentrations 
of, in this case ammonia, gaseous analytes in exhaled breath. The system of detection relies 
upon the intrinsic properties of the metal oxide films being an n-type semiconductor, which 
behave as reducing agents due to an excess of electronic charge in the metal-oxide lattice. 
The resistance of the nanoparticles is chiefly controlled by the concentration of chemisorbed 
oxygen species, O2
-
, O
-
, and O
2-
 which trap electrons on the surface of the WO3 film. The 
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interaction proceeds via transfer of electrons from the conduction band to the adsorbed 
oxygen, in a manner summarised as follows (eq.6): 
 
-
(ads.)
-
2
(ads.)
-
2(ads.)2
(ads.)22(gas)
2OeO
OeO
OO
                                                   (eq.6) 
 
 The transfer of electrons out of the conduction band results in a decrease in electron 
concentration in the film and a corresponding increase in the resistance of the film and hence 
sensor (34). The reducing hydrogen species found on acetone react with the adsorbed oxygen 
species on the metal oxide film, releasing an electron, resulting in a decrease in the resistivity 
of WO3. The reaction can proceed via two pathways as described below, (eq.7) (35): 
 
e
e
eads
2
-
33
-
33
-
(gas)33
)(vacancies3(bulk)3
-
3
-
(gas)33
-
23.)(
-
(gas)33
COOCO
COCHCOCH
OCH  COCHO  COCHCH
O  COOHCHO  CHOCH
CH3O  CHOCHOHCOCHCH
OH  CHCOCHO COCHCH
                      (eq.7) 
 
 Another requirement of any viable sensor is a high selectivity for the gas analyte in 
consideration. The study by Righettoni et al.  found that a 10% Si doped WO3 film, 
sensitivity to acetone was 4.7-6.7 times greater that that to ethanol. This was comparable to a 
Cr doped film described above in dry conditions. In contrast, the sensor response, S was only 
1.7 times greater than that for ethanol for a pure WO3 based sensor. Furthermore, whilst the 
sensor was found to be most sensitive to acetone in dry air, with sensitivity decreasing as the 
relative humidity, RH, increased to human breath levels of 89-97% with a mean RH of 93% 
(36). The corollary to such an observation is that simultaneous measurement of RH is crucial 
for accurate determination of EB acetone concentration.  
 
 The rational behind this cross sensitivity is due to an increase in conductivity when 
water vapour reacts with the film surface. Three possible mechanisms have been proposed 
(37), however all three are based upon increased adsorption of either water molecules, or 
hydroxyl groups onto the surface leading to a donation of electric charge into the conduction 
band, or similarly an increase in the density of charge carriers (38). 
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  Despite this, it was found that the CS value of 4% going from 80% RH to 90% RH is 
sufficiently small compared with the CS of 67% from dry air to 90% RH that formal 
regulation of RH in the EB is not necessary with a Si doped WO3 sensor. The following graph 
is taken from the report of Righettoni et al.  And summarises the optimal conditions for 
acetone detection (fig.7): 
 
 
 
Fig.7 Graph showing the response sensitivity of an Si-doped WO3 film sensor as a function of RH and % doping 
at 400 C. 
 
 It has been known for some time that metal oxide semiconductors display a change in 
conductivity when gases interact with the surface, a feature which is highly sensitive to the 
composition of the gas (39). Recent advances in sensor materials has lead to the classification 
of gases as either oxidising or reducing, depending on whether the change of sign in 
conductivity is positive or negative respectively. Metal oxides are classified as p-type if  a 
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resistance increase is recorded when interacting with a reducing gas, and a resistance 
decrease when exposed to an oxidising gas. Logically, n-type metal oxides exhibit the 
opposite behaviour. The classification of n- or p-type semiconductor is used as it is proposed 
that this reflects the major type of charge carrier for the two cases, (i.e. positive charge carrier 
for the p-type semiconductor, an excess of negatively charged carriers in the case of the n-
type) (8). 
 
  There are of course limitations in the use of metal oxides in sensor technology. Both 
thin and thick film metal oxides show variable electrical properties due to grain coalescence 
(i.e. a detrimental interaction between neighbour grains), porosity modification and grain 
boundary alteration (40). These electrical variances become more critical as the temperature 
increases, a situation which is often necessary to ensure the reversibility of chemical reactions 
on the sensor surface. One way to counteract this is to use highly crystalline nanostructures, 
such as nanowires, or nanobelts in sensor technology as they exhibit greater stability (41). 
 
 Further work has detailed the mechanism of water vapour interaction with a tin oxide, 
SnO2 sensor with respect to carbon monoxide, methanol, methane, butane and propane (42). 
It is suggested that there are two mechanisms by which water interacts with the sensor 
surface, the first being the dissociation into hydroxyl groups which act as electron donors, the 
second proposes that hydrogen atoms react with oxygen atoms in the lattice to produce 
oxygen vacancies which then act as electron donors. Both mechanisms cause an increase in 
the sensor’s electrical conductance (43). It is suggested that in some cases, doping of the 
sensor with, in this instance, palladium (wt. 1%) and vanadium (wt. 0.08%) can reduce the 
interference of water vapour with the electrical conductance. Doping with palladium, 
decreased the interference with all gases, however vanadium showed a drastic decrease in 
interference with ethanol, but little change with the other analytes. Moreover, at least with 
CO, it was found that application of a viscous film made of tin(II) ethyl-hexanoate mixed 
with a polymer solution of ethylhexyl alcohol dramatically reduced the effect of water vapour 
interference. The film was found to be highly non-selective to gases, with almost negligible 
conductivity. Whilst the same effect was not found with the alkyl analytes, the potential for 
metal organic films to act as a barrier to render the effect of humidity irrelevant is clear.  
 
 In addition studies have shown that preparation of a nanocomposite solid solution of 
SnO2-TiO2 combines the excellent gas sensitivity of SnO2 (44) with the selectivity of TiO2. 
furthermore, where concentrations of Ti are kept below wt. 5% it was shown that cross 
sensitivity to humidity, the limiting factor in application of SnO2 sensors to widespread use, 
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is decreased (37). It has previously been found that the resistivity of Sn1-xTixO2 solid state 
solutions increased up to 80% Ti content. Hence for the purpose of sensor technology, Ti 
content was kept at 5% or below (45).  
 
As can be seen in the following diagram, increasing the content of Ti in the SnO2 
sensor decrease cross sensitivity to relative humidity [tested between 0%, dry air, and 60% 
RH] At 4.6% Ti content, the sensor response decreases from 53 to 48 at 50ppm EtOH when 
increasing RH from dry air to 20%. More impressively, increasing RH from 20% to 60% 
shows negligible cross sensitivity. It is claimed that this reduction in CS arises from increased 
desorption of hydroxyl species on the surface of the modified sensor. Moreover, close to this 
optimal % content, (3.7%) the sensitivity of the solid state mix was double that compared 
with the unmodified SnO2 sensor. This can be attributed to enhanced crystal defects and 
presence of Ti atoms on the surface of the sensor. 
 
 
Fig.8 Sensor response relative values as a function of EtOH concentration with respect to Ti contents of 0, 1, 4.6 
and 5.5% respectively. 
  
Research has recently focussed on the potential to modify solid-state metal oxide sensor 
arrays to improve the selectivity and selectivity. This modification can be achieved through 
the incorporation of zeolites onto the surface of a porous metal-oxide sensor (46). In the 
referenced study, two zeolites, LTA and ZSM-5, were independently tested for response to 
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modified artificial air and either carbon monoxide or ethanol on WO3 and CTO porous 
sensors. It was expected that the zeolite layer acts as a further diffusion zone, hence altering 
the diffusion gradient of the gas to the sensor, or else actively modify the gases, either 
through reaction of cracking, to produce new products which show either a reduced or 
enhanced sensitivity to the metal-oxide sensor. It was found that there was no coordinated 
change in sensor response. This was again found when the test gases were ethanol and 
isopropyl alcohol (47). It was found that both enhanced and diminished responses were 
gained with modification of a CTO sensor with zeolites described above. An enhanced 
response, such as with H-LTA modified surface to ethanol, can be attributed to the catalytic 
reaction of the zeolite with the gas, forming products which the sensor is considerably more 
sensitive. The work demonstrates the opportunities to tailor zeolite enhanced metal-oxide 
sensor arrays to specific applications with high gas sensitivity.  
 
 Clearly there is a viable potential for metal oxide based sensors. Other technologies 
are also being actively developed. This is not just restricted to traditional inorganic materials 
either. An interesting approach to sensor design is to mimic the complex olfactory systems 
found in mammals. Indeed studies have shown that with only a few weeks training, dogs 
were able to accurately identify breast and lung cancer patients, from their exhaled breath 
alone, with remarkable accuracy, showing sensitivity of 0.88 and 0.99 respectably compared 
with traditional medical diagnosis (48).  
 
 Recent investigation has focussed on designing a multiple sensor array that is able to 
collect and transmit hundreds, if not thousands of uncorrelated signals which are then fed to a 
pattern recognition system which is able to recognise predetermined ‘fingerprints’ of breath 
analytes. (49) A system of Deoxyribonucleic acid (DNA) coated, singly walled, carbon 
nanotubes (CNT’s) is employed. This is made difficult as current preparative methods do not 
allow for fabrication of single, semiconducting CNT’s. Hence, selective sampling is required 
to find desired CNT’s from batches made from standard chemical vapour deposition of 
carbon tubes onto a silicon substrate and gold electrodes. The selected CNT’s were then 
functionalized with the application of one of two DNA base oligimer solutions. The 
transconductance of the CNT’s was measured before, during, and post exposure to five 
odorants (fig.9): 
 
INTERNATIONAL JOURNAL ON SMART SENSING AND INTELLIGENT SYSTEMS, VOL. 5, NO. 2, JUNE 2012 
417
 Fig.9 The five chemical odorants exposed to the ss-DNA coated CNT’s 
 
 The selection of DNA bases and odorants was in accordance with a desire to critically 
examine the success of the sensor in comparison with earlier work in which single strands of 
DNA oligimers were labelled with fluorescent dyes were exposed to the same five odorants 
(50). This primary study found that DNA interactions with odorants was both specific to the 
base code used and highly sensitive (fig.10): 
 
 
 
Fig. 10 Graph showing the relative strength of fluorescent response to five odorants for a single strand of DNA 
base sequence.  
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  As is clear, sensor response increases with the concentrations of odorants, however 
even at very low concentrations (ppbv for dinitrotoluene, ppmv and above for the other four) 
there is a recognised and sufficient response. The study also found that particular DNA base 
sequences had selective responses to the odorants, i.e. changing the sequence or identity of 
the DNA strand led to markedly different relative responses of fluorescence. This is 
promising in that it reasonably follows that electronic noses could be constructed with many 
individual sensor arrays each with a preselected ss-DNA the product being sufficiently 
sensitive to a vast range of VOC’s. 
 
 Interestingly, comparison of the two studies, White et al. and Johnson et al. found that 
any correlation between increased fluorescence on the one hand, and increased 
transconductance on the other is weak at best. For instance, both studies investigated diethyl 
methylphosphonate (DMMP) as an odorant. It was found that, when using the same DNA 
base sequence, fluorescence did not show any appreciable difference, and yet the electrical 
measurements in the latter study showed a 14% reduction in current. This was repeated even 
with a change in DNA base sequence. Hence whilst both measured variables were respondent 
to all five observed odorants, cross selectivity was only partial and needs further investigation.  
 
 The mechanism by which the DNA interacts with the odorants and subsequent change 
in fluorescence has not been fully elucidated however research by White et al. suggests that 
small changes in the three dimensional structure of the DNA chain arising from interaction 
with the hydration sphere, i.e. namely two way hydrogen bonding between the nucleic bases 
and water molecules, make the DNA chain responsive to subsequent interaction with the 
odorants (51). Moreover, the structural nature of the singularly walled CNT’s give it unique 
properties directly applicable to this field of sensing. All atoms are exposed to fictionalization 
by the ss-DNA chains. The nature of DNA-CNT interaction has been characterized by a 
favourable π-π interaction (52) in which the DNA chain coils around the carbon nanotube 
with a biased right/left direction. This exposes the hydrophilic phosphate sugar backbone 
(fig.11): 
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 Fig. 11 Pictorial representation of the ss-DNA-CNT interaction showing the exposed hydrophilic phosphate 
sugar backbone in yellow, DNA bases in red.  
 
 The work of Staii et al. highlighted the self-regenerating nature of the sensor arrays, 
without loss of sensitivity or selectivity over fifty odour cycles. What is clear is that 
application of ss-DNA-coated CNT’s offers a great opportunity for a fabricated ‘electronic 
nose’. Importantly they offer a more compact device and simpler implementation that 
chemicapacitors (53) as well as a more direct and condensed form of data output compared to 
the optical displays of some electronic noses.  
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Breath Analysis and Cancer Detection: 
  
 In 2010 it is projected that there will be 1,529,560 new cancer cases and 569,490 
deaths directly attributed to cancer in the US alone (54). Whilst there has been a decrease in 
mortality rates for both sexes over the last 20 years, cancer still remains the number one 
cause of deaths among persons aged under 85.  
 
 Conventional detection techniques rely heavily on computer tomography (CT) or the 
more sensitive CT positron emission tomography (CT/PET). However even with the latter, 
detection is limited to tumours which have already reached 1-10 billion malignant cells 
before they become visible, consequently the risk of the tumour having already spread by 
micro-metastasis is significant. Along with other diagnostic techniques (mammography, 
ultrasound, breast magnetic resonance imaging (MRI) etc.) there is concern that widespread 
use contributes towards the incidence of cancer, some estimates placing this as high as 1-2% 
(55). Combined with other factors such as high economic cost of role-out and low specificity, 
the argument for developing a field of diagnosis based upon non intrusive breath analysis is 
strong. 
  
 The lack of validated data, and standardized operating techniques is a barrier to the 
acceptance of breath analysis as a diagnostic technique, and this is particularly acute with 
cancer where there has been little validation and extension of existing research (56). 
 
It is beyond the scope of this review to detail progress made with all forms of cancer, and as a 
consequence only the current key field of research, lung cancer diagnosis will be reported on.  
 
 Of all cancers, it is lung that claims the most lives, 20% of cancer fatalities in the EU 
alone. The assumption that due to the proximity of malignant cells to the airways that 
biomarkers are more prevalent in exhaled air, has made lung cancer the primary focus of 
research in recent years. Preliminary research in the 80’s conducted by O’Neil and Gordon 
made a chemical analysis of VOC’s that were present in the exhaled breath of lung cancer 
patients (57). These consisted of mainly alkanes and methylated alkanes,  and more recent 
research has attempted to link the internal  production of these biomarkers to the oxidative 
stress of proteins, DNA and lipids which occurs as a result of cancer initiation (58). The 
suggested route is the production of reactive oxygen species (ROS)  from the peroxidation of 
fatty acids found in cell membranes of cancerous cells. DNA oxidation has also been cited as 
a marker of carcinogenic cells.  
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  Fig.12 shows an example reaction pathway for the peroxidation of arrchidonic acid (1) 
to pentane (8). The reaction steps involve production of alkyl radicals (2) followed by 
internal conversion to conjugated diene radicals. Oxidation of diene radicals produces 
peroxyl radicals which can undergo three separate, competing reactions: 
 
1. Hydrogen abstraction (as shown) 
2. Cyclisation and intramolecular rearrangement 
3.  scission 
 
 The first reaction route proceeds, forming a lipid hydroperoxide species which is 
reduced by an added Fe(II) species proceeding to alkoxyl radicals. (6) Following 
hydrogenation from a polyunsaturated fatty acid, the species is cleaved into a pentyl radical, 
which undergoes further hydrogen abstraction to produce the recognised biomarker pentane.  
 
Carbon 
Chain IUPAC Name Proposed Origins 
C2 Ethane n-3 PUFA: linolenic acid; isoleucine 
  Ethene linolenic acid; methionine 
  Ethyne unkown 
C3 Propane n-4 PUFA, linoleic acid; leucine; hemoglobine 
  Propene unkown 
C4 2-Methylpropane hemoglobine 
  Butane myristoleic acid, limoleic acid, (iso)leucine 
  1-/2-Butene linoleic acid 
  2-Methylpropene leucine 
C5 2-Methylbutane unkown 
  Pentane n-6 PUFA: linoleic acid, arachidonic acid 
  1-Pentene myristoleic acid, linoleic acid 
  
2-Methyl-1,3-
butadiene unkown 
C6 Hexane n-7 PUFA 
  Hexene vaccenic acid 
C7 Heptane oleic acid 
  Heptene vaccenic acid 
C8 Octane oleic acid 
Table.1 hydrocarbon biomarkers associated with cancer and their proposed origins. 
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Figure 12. Peroxidation of arschidonic acid to pentane. (Kneepkens et al.) 
 
Biomarkers and their origination were tabulated by Kneepkens, and are shown in Table 1. 
above. 
 
Arachidonic acid 
Lipid alkyl radical 
Conjugated lipid 
diene radical 
Lipid peroxyl 
radical 
Lipid 
hydroperoxide 
Lipid alkoxyl 
radical 
Pentyl radical 
Pentane 
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 In the two studies described above, gas chromatography mass spectrometry (GC/MS) 
was the method of analysis utilised to identify the relevant VOC attributed to lung cancer. 
From the O’Neil study, just nine biomarkers were found in sufficient considerations and not 
classified as ‘ambient’ to be potential diagnostic biomarkers. A further study by Phillips et al. 
utilised a portable device consisting of activated carbon tubes to capture VOC’s, analysed by 
GC/MS. The result was a proposed twenty two biomarkers for lung cancer, consisting of 
cyclic and acyclic alkanes, cyclic alkenes, aromatics, and aldehydes (59). 
  
 The problems associated with GC/MS, notably the complexity of analysis has made 
the formulation of a ‘standard set’ of biomarkers exceedingly difficult and has led, over the 
past twenty years, to the development of a new device, the electronic nose. Whilst there are 
many variations the basic design is of an array of non-specific chemical sensors, able to 
detect any VOC, however each element of the array has specific sensitivities to certain 
compounds. The result is that a macroscopic ‘fingerprint’ of the exhaled breath is formed, 
much in replication of the human olfaction system (60). In a study by Di Natale et al. a 
Quartz microbalance (QMB) sensor was used, a technology which is based upon the change 
in fundamental frequency of oscillations of a thin quartz crystal that occur upon absorption or 
desorption of gas phase molecules (61). Upon absorption of the gas molecule, the oscillating 
mass of the quartz crystal changes, resulting in a change in the oscillating frequency, as 
determined by the Sauerbrey law (eq.8): 
 
                                              (eq.8) 
 
Where f0 is the fundamental frequency of oscillation, Cf the mass sensitivity constant and A 
the area of the sensor.  
 
 As already mentioned, each element of the sensor array is particular sensitive to 
specific organic compounds. This specificity is achieved by using variations of metal 
porphyrin coatings. The basic structure is adapted to sensor analysis as the organic 
compounds exhaled in breath form particularly effective ligands to metal ion cores of such 
structures. Acute sensitivity to particular VOC’s arises from altering the outer substituents in 
the porphyrin ring, giving rise to wide ranging flexibility and sensitivity of exhalents (62). A 
typical structure of such a porphyrrin ring is shown in Fig. 13; 
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Fig. 13 Cobalt tetramethoxyphenylporphyrin 
Co(TPP) an organo-metallic porphyrin ring used as a Quartz crystal coating. Square planar in structure, the 
VOC’s absorbed attach via the empty d-orbitals on the metal ion centre. 
 
 The study by Di Natale et al. used a statistical analysis based upon partial least-
squares discrimination (PLS-DA) a linear model. It was noted that all 35 cancer confirmed 
patients in the study were positively diagnosed however whilst e-noses, as they have become 
known are able to identify a wide range of organo-chemicals in exhaled breath, the chemical 
basis for similarities and differences between ‘healthy’ and exhaled breath from patients with 
lung cancer is unknown, and as such sensor techniques should be used in conjunction with 
traditional analytical techniques such as GC/MS to provide a deeper understanding (63).  
 
 Following on in 2005 Machado et al. published a study using a sensor array of 32 
polymer composites. The results were consistent with previous GC/MS studies and identified 
pentene, isoprene, acetone and benzene as major biomarkers for lung cancer. The results 
showed the electronic nose to have 71.4% sensitivity and 91.9% specificity (64). For contrast 
a recent diagnostic study using positron emission topography (PET) had a 98.6% sensitivity 
and 77.8% specificity (65). On this basis, the electronic nose has a clear potential to be an 
affordable, non-invasive but above all accurate screening tool. Machado did highlight areas 
of concern in his study, citing the relative advanced stages of lung cancer in the study 
population as a limitation. Given that it is early detection that is necessary for increasing the 
survival rate, breath analysis as a diagnostic tool must be verified as accurate in the early 
stages of cancer initiation.  
 
 Peer review cast doubt on Machado’s findings in 2005 however, with the validity and 
as a consequence, potential of the electronic nose to be diagnostic tool questioned. It was 
claimed that the biomarkers attributed to lung cancer were determined via GS/MS as in 
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previous studies and not using the electronic nose which is unable to identify individual 
species, taking an all encompassing ‘fingerprint’ of the analyte instead. Another claim was 
that current e-noses in use lack the sensitivity to detect many VOC’s that are present in low 
concentrations in human breath, typically at parts per trillion well above the detection limit of 
current sensors (66). Further comment has been made that the disagreement over study 
populations and associated risk factors, such as old age and smoking, highlights the problems 
facing accreditation of the electronic nose. Namely risk factors in a population should not be 
treated as a calibration basis in a medical study (13).  
 
 Within the last few years advances in technology have made sensors and the 
subsequent statistical analysis of the data more robust and better able to deliver reliable 
results. In 2008, Phillips et al. employed an advanced statistical analysis to re-evaluate earlier 
data. In contrast to the linear method employed until recently, a multivariate non linear 
analysis was carried out, using weighted digital analysis (WDA). In this study 30 suspected 
disease markers were identified and given a ‘weighting’ which is directly linked to the 
significance of their presence and the associated likelihood of being caused by the metabolic 
changes brought about by cancer. The VOC’s identified were from previous study groups 
(67). Results showed that the WDA had sensitivity of 84.5%, and a specificity of 81.0%), 
comparable to CT screening effectiveness and greater than a similar multilinear regression 
analysis carried out on the same data which only wielded a sensitivity of 68.4% and 
specificity 73.5%. Importantly the results were not affected by confounding factors such as 
age and smoking status.  
 
 As stated, concern has arisen over the influence of such confounding factors on the 
results of studies. Attention should be given to age and smoking as such factors, in that both 
contribute to the incidence and likelihood of developing cancer, and as such a potential 
screening tool would be aimed at such risk populations. Yet the influence of factors on the 
makeup of exhaled breath and the constituent VOC’s is unknown and disputed when not 
controlled in study populations as was highlighted by critique of the Machado study. 
 
 Comparable studies by Steeghs et al. and Wehinger et al. differed from those 
described above in that the exhaled breath was not preconcentrated after collection. Both used 
proton transfer reaction – mass spectrometry (PTR-MS) and found significantly less 
biomarkers compared with the preconcentration approach. Whilst PTR-MS removes the 
influence of ambient air constituents such as CO2, NO and O2 etc it must be noted that due to 
their low proton affinity some alkanes, methylated alkanes and alkenes are not detected by 
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PTR-MS (68). Only acetone, isoprene, methanol and acetylaldehyde were presented as 
biomarkers in the first study, and only two were given in the former. Formaldehyde and iso-
propanol. (Note however that PTR-MS is not able to distinguish between species of the same 
molecular weight and as such identifications are only tentative) (69). A point to be taken must 
be that preconcentration is a requirement if potential biomarkers are not to be missed and 
become detectable at biologically relevant levels.  
 
 Doubtless it will be the case that new technologies, more advanced sensors and 
improvements in study controls will lead to enhancements in the ability of breath analysis to 
act as a credible diagnostic tool. However without the establishment of systematic procedures 
and standardized practices there is little scope for the field to move beyond research. As has 
been shown above, the many applicable statistical analyses available have a considerable 
effect on the predictions of biomarkers and their accuracies (70). If these challenges can be 
overcome it is clear that breath analysis has the potential to be an economical, non-invasive 
diagnostic tool that in conjunction with existing screening tools can save lives. 
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Breath Analysis applied to Renal and Hepatic Diagnosis. 
 
 The presence of acetone in human breath was first reported by an English physician, 
John Gallo in 1798, noting a constituent in exhaled breath with the odor of decaying apples. 
In 1857, this compound was identified as acetone (71). The mechanism for acetone 
production in vivo arise from the metabolism of hepatocytes via the decarboxylation of 
excess acetyl-CoA, which itself comes from β-oxidation of fatty acids. In cases of ketonemic 
patients, or severe diabetes, metabolism of fats is increased, resulting in a lack of 
oxyloacetate and a subsequent buildup of acetyl-CoA (fig.14) (72). 
 
 
Fig.14 Generation of ketone bodies via decarboxylation of acetyl-CoA 
 
 In addition it has been reported that the mean acetone concentration in EB rises 
progressively with blood glucose concentration in diabetic patients (73). A study conducted 
in 2010 reported the use of a multiple array of twelve metal oxide sensors to measure the 
concentration of acetone in the EB of 198 patients [108 healthy subjects, 90 clinically 
diagnosed diabetic patients.] The aim of the study was to not only identify cases of diabetes 
with respect to acetone concentration, but also determine the blood glucose concentration of 
the set. When analyzed using two principle components (PC) it was found that two sets of 
data were clearly visible, diabetic and healthy. Moreover, the two PC’s combined could 
account for 83.31% of the variation in the data. (fig.15) 
 
 Determination of blood glucose levels was more problematic.  It was found that at 
low glucose concentrations, the sensitivity of the sensor array to acetone was indisernible for 
diabetic patients compared with healthy subjects. As blood glucose concentration increased, 
sensor response likewise increased., Although not perfect, it was found that when a linear 
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regression was applied to the data, accurate categorization (i.e. low, boundary, high and very 
high blood glucose conc.) was possible between 50-75% of the time (74). Whilst this is 
someway off the required sensitivity levels, the potential of a noninvasive method for 
frequent blood glucose monitoring negating the potentials hazards of blood sampling is 
obvious. 
 
 
Fig.15 Classification of data according to two PC’s.  
 
A comparative method is illustrated by A. Hryniuk et al. in which thermal desorption 
(TD) is offered as a means of offline breath analysis. This can advantageous where clinical 
settings are not immediately available, for instance at home, or field testing. Initial samples 
are desorbed into a carrier gas, namely helium and subsequently heated to 300C releasing the 
volatiles for analysis. TD is often coupled with gas chromatography (GC) This gives 
excellent chemical resolution however the analysis is slow, often taking between 20 and 40 
minutes and required calibration with a standard data set for the volatiles, further extending 
the diagnostic (75).  
 
Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) offers an alternative to TD-
GS offering real time analysis. This allows measurement of trace volatiles even when mixed 
with high concentrations of background gases, by exposing to charged precursors such as 
H3O, NO
+
 and O2
+
 (76). Indeed, by knowing the reaction rate constant between the precursor 
ions and volatile gases [producing known charged species] real time quantification is possible 
without the need for a standardized base.  
INTERNATIONAL JOURNAL ON SMART SENSING AND INTELLIGENT SYSTEMS, VOL. 5, NO. 2, JUNE 2012 
429
 Fig.16 Comparison of TD/SIFT-MS with direct real time SIFT-MS detection of acetone. 
 
When comparison was made between real time and delayed SIFT-MS using TD there 
was a near 1:1 ratio of the concentration of acetone detected (fig.16). This suggests that TD is 
a viable, non-detrimental procedure for capturing EB allowing latter date analysis. Moreover, 
coupling with SIFT allows for vastly increased analysis times, generally less than 5 minutes 
with increased gas sensitivity (77). 
 
Similar methods have been used in the detection of ammonia and other nitrogen based 
compounds proposed as biomarkers of renal disease. These biomarkers arise from the 
inability of the kidneys to effectively filter the blood, resulting in a build up of nitrogen based 
compounds (urea) which is attributable to the ammonia odor on the breath of renal disease 
patients (78).  
 
Previous research has focused on non ammonia volatiles such as dimethylamine and 
trimethyamine using tradition gas chromatography, mass spectroscopy methods requiring 
pretreatment of the exhaled breath (79). As previously reported with acetone measurement, 
SIFT-MS offers increased sensitivity and is ideally suited to gases in complex mixtures, able 
to detect concentrations down to 10-20 ppbv (80). Research by Davies et al. found that the 
mean ammonia concentration in EB of patients suffering from uremia was approximately 
4880 ppb with a range of 820-14700ppb compared with a healthy sample with mean 960ppb, 
range 425-1800ppb (81). Despite the large range in values it was found that there was a linear 
correlation, with coefficient r=0.57, between breath ammonia concentration and blood plasma 
urea concentration. Significantly, there was found to be no link between hydrolysis of urea in 
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the oral cavity and the concentration of ammonia indicating that the raised levels detected 
could be directly attributed to a perversion of metabolic pathways in uremic patients.  
 
In keeping with the recent focus of research, Lin et al. proposed the use of an 
electronic nose to measure the concentrations of several biomarkers linked to first stage 
uremia; dimethylamine, trimethylamine, ammonia and monomethylamine in exhaled breath. 
The detector system consisted of six 12MHz quartz crystals coated with synthetic peptides 
offering different selectivity’s and sensitivities (82). The population sampled consisted of 
healthy individuals as well as those suffering from chronic renal insufficiency (CRI) and 
chronic renal failure (CRF). As can be seen in Table.3 Accurate distinction of healthy 
individuals had 100% accuracy, and whilst there was some overlap between uremia and 
CRI/CRF sufferers, identification was generally accurate particularly with CRI/CRF cases. 
 
 
Table.3 Classification of the sample population using a synthetic peptide functionalized quartz crystal electronic 
nose. 
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Future Developments – Novel Electronic Nose Sensors 
 
As previously mentioned the high specificity of e-noses to particular diseases prevents 
further application in medical diagnosis. Recent work has tried to correct this. Two studies 
have recently surfaced presenting set ups of electronic noses able to distinguish between, in 
the first case; healthy patients and cases of renal disease, diabetes and airway inflammation 
(83) and in the second; cases of lung, breast, colorectal and prostate cancer (84).  
 
The first report follows on from earlier work detecting acetone in EB with an array 
consisting of 12 metal oxide sensors. The study was extended to distinguish between not only 
healthy vs. diabetic, but between three independent medical conditions. Results showed a 
relatively high degree of accuracy in separating cases of the three diseases, summarized in 
table 2. below:  
 
 
Table 2. E-nose sensitivity and selectivity with respect to renal disease, diabetes and airway inflammation 
determination. 
 
 It is apparent that the e-nose consisting of 12 individual metal-oxide sensors was able 
to distinguish between the three diseases with a relatively high degree of accuracy, in all 
cases >75% correct identification.  
 
Further to this, the second study utilized functionalized gold nanoparticles (GNP’s), 
5nm in diameter dropped onto ten pairs of gold electrodes placed on device quality silicon 
wafers. The GNP’s were functionalized with organics [Dodecanethiol, 4-methoxy-
toluenethiol, hexanethiol, 11-mercapto-1-undecanol, decanethiol, octadecanethiol, tert-
dodecanethiol, 1-butanethiol, 2-ethyl-hexanethiol, 3-methyl-1-butanethiol, 2-
mercaptobenzoxazole, 11 mercapto-1-undecanol, 2-mercapto-benzyl alcohol, and 3-methyl-
1-butanethiol] (85). In all 14 functionalized gold nanosensors were included.  
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GNP’s are ideal as they combine the robust processability of inorganic materials, with 
the high selectivity shown by organic molecules to cancer biomarkers (86). Moreover it is 
possible to reliably control the size of the nanoparticles, hence the ratio of volume to surface 
area which determines the interaction of the nanoparticle surface with the gas analyte. The 
mechanism of interaction is such that each sensor responds independently to the various 
VOC’s contained in the EB producing a unique odorant fingerprint, without the necessity to 
identify the individual VOC’s as is the case with GC-MS.  
 
Using the aforementioned double principle component analysis it was clearly evident 
that the four cases of cancer plus healthy individuals could be separated with minimal overlap 
(fig.17): 
 
 
Fig.17 Principal Component Analysis plot of the GNP’s sensor array response of all cancer cases (LC = Lung 
cancer, BC = Breast Cancer, CC = Colorectal Cancer and PC = Pancreatic Cancer).  
 
 The study by Peng et al. proposed that the use of GNP’s in a single sensor array e-
nose have five key advantages over comparable detection methods, namely GC-MS: 
 
1. No premodification of the gas samples was required (preconcentration, 
dehumidification etc.). 
2. Operation is quick and simple, requiring little training. 
3. No selection of the data is required for accurate separation of the tested 
group into cancer type. 
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4. The four cancer types plus healthy subject form distinct regions with little 
overlap. 
5. The GNP sensor array was insensitive to confounding factors (age, gender, 
smoking habits etc.) 
  
 Whilst the study dealt with only a relatively small sample population (177 individuals) 
it acts as a conceptual proof that multi-functionalized GNP’s offer a route into medical 
diagnosis uniquely able to distinguish between diseases in a mixed, or unspecified sample.  
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 Summary and Conclusions: 
 
This review has tried to give only a brief overview of the state of breath analysis for 
medical diagnosis, accounting for early break through work and the initial identification of 
possible VOC biomarkers and the process of associating these potential biomarkers to 
metabolic disturbances, which occur as a result of disease. It has been noted that whilst the 
technology, and ability to analyse the data has improvement vastly of the past four decades, 
attributed accordingly to the rise and development of computer technology, challenges 
remain.  
 
There is still a strong requirement for a standardized method of collection, treatment 
and conditioning of sampled exhaled breath, which allows for cross comparison of results and 
findings. Moreover, the difficulties associated with compounding factors such as age, gender 
and lifestyle make this standardization incredibly difficult to implement. Nether the less, it 
has been shown that with adequate research difficulties can be overcome, as exampled by the 
development of promising methodologies to negate the effect of relative humidity and 
inconsistencies associated with water vapour interaction. 
 
Whilst acknowledging the benefits of various technologies such as GC-MS, SIFT-MS, 
FID, & IMS to name but a few, recent work, and the thrust of future research, has focussed 
on the requirements for a low cost, easy to use, quick and portable device primarily centred 
around electronic nose technology, whereby an array of sensors are able to analyse 
unmodified exhaled breath to produce an door fingerprint from which it is possible to not 
only quantify concentrations of known disease biomarkers but also accurately distinguish 
between diseases and make reliable diagnoses. This has been realised through the 
incorporation of metal oxide semiconductor arrays, further to which fictionalisation has 
allowed for greater sensitivity and selectivity, the two characteristics upon which such 
devices can be judged.  
 
All of this of course is irrelevant unless accurate diagnosis can be made, giving the 
medical field another tool to try and save lives, the ultimate goal. This review has highlighted 
promising areas of cancer detection, renal and hepatic disease diagnosis as cases where 
advances in technology, understanding and design have made possible accurate measurement 
of breath biomarkers. Of course further research is needed, and problems remain, but with 
further work it is hoped that within a few years, rollout of breath analysers will be possible. 
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